Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

Regulation of the expression of the oncogene EVI1 through the use of alternative mRNA 5'-ends.

Aytekin M, Vinatzer U, Musteanu M, Raynaud S, Wieser R.

Gene. 2005 Aug 15;356:160-8.

PMID:
16014322
2.

Conservation and expression of a novel alternatively spliced Evi1 exon.

Alzuherri H, McGilvray R, Kilbey A, Bartholomew C.

Gene. 2006 Dec 15;384:154-62. Epub 2006 Aug 15.

PMID:
17014970
3.

Conservation and expression of an alternative 3' exon of Runx2 encoding a novel proline-rich C-terminal domain.

Terry A, Kilbey A, Vaillant F, Stewart M, Jenkins A, Cameron E, Neil JC.

Gene. 2004 Jul 7;336(1):115-25.

PMID:
15225881
4.
5.

Quantitative comparison of the expression of EVI1 and its presumptive antagonist, MDS1/EVI1, in patients with myeloid leukemia.

Vinatzer U, Mannhalter C, Mitterbauer M, Gruener H, Greinix H, Schmidt HH, Fonatsch C, Wieser R.

Genes Chromosomes Cancer. 2003 Jan;36(1):80-9.

PMID:
12461752
6.

High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated.

Lugthart S, van Drunen E, van Norden Y, van Hoven A, Erpelinck CA, Valk PJ, Beverloo HB, Löwenberg B, Delwel R.

Blood. 2008 Apr 15;111(8):4329-37. doi: 10.1182/blood-2007-10-119230. Epub 2008 Feb 13.

7.

Zinc finger transcription factor ecotropic viral integration site 1 is induced by all-trans retinoic acid (ATRA) and acts as a dual modulator of the ATRA response.

Bingemann SC, Konrad TA, Wieser R.

FEBS J. 2009 Nov;276(22):6810-22. doi: 10.1111/j.1742-4658.2009.07398.x. Epub 2009 Oct 16.

10.

Human transcription factor Sp3: genomic structure, identification of a processed pseudogene, and transcript analysis.

Moran KM, Crusio RH, Chan CH, Grekova MC, Richert JR.

Gene. 2004 Oct 27;341:235-47.

PMID:
15474306
11.

Expression and prognostic significance of different mRNA 5'-end variants of the oncogene EVI1 in 266 patients with de novo AML: EVI1 and MDS1/EVI1 overexpression both predict short remission duration.

Haas K, Kundi M, Sperr WR, Esterbauer H, Ludwig WD, Ratei R, Koller E, Gruener H, Sauerland C, Fonatsch C, Valent P, Wieser R.

Genes Chromosomes Cancer. 2008 Apr;47(4):288-98. doi: 10.1002/gcc.20532.

PMID:
18181178
12.

Identification of low-abundance alternatively spliced mRNA variants by exon exclusive reverse transcriptase polymerase chain reaction.

Wang F, Zhao Y, Hao Y, Tan Z.

Anal Biochem. 2008 Dec 15;383(2):307-10. doi: 10.1016/j.ab.2008.09.002. Epub 2008 Sep 10.

PMID:
18817741
13.

High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities.

Gröschel S, Lugthart S, Schlenk RF, Valk PJ, Eiwen K, Goudswaard C, van Putten WJ, Kayser S, Verdonck LF, Lübbert M, Ossenkoppele GJ, Germing U, Schmidt-Wolf I, Schlegelberger B, Krauter J, Ganser A, Döhner H, Löwenberg B, Döhner K, Delwel R.

J Clin Oncol. 2010 Apr 20;28(12):2101-7. doi: 10.1200/JCO.2009.26.0646. Epub 2010 Mar 22.

PMID:
20308656
14.

Alternative splicing and nonsense-mediated mRNA decay in the regulation of a new adenomatous polyposis coli transcript.

De Rosa M, Morelli G, Cesaro E, Duraturo F, Turano M, Rossi GB, Delrio P, Izzo P.

Gene. 2007 Jun 15;395(1-2):8-14. Epub 2007 Jan 12.

PMID:
17360132
15.
16.

Identification of novel first exons in Ad4BP/SF-1 (NR5A1) gene and their tissue- and species-specific usage.

Kimura R, Yoshii H, Nomura M, Kotomura N, Mukai T, Ishihara S, Ohba K, Yanase T, Gotoh O, Nawata H, Morohashi K.

Biochem Biophys Res Commun. 2000 Nov 11;278(1):63-71.

PMID:
11071856
17.
19.
20.

Ecotropic viral integration site-1 is activated during, and is sufficient for, neuroectodermal P19 cell differentiation.

Kazama H, Kodera T, Shimizu S, Mizoguchi H, Morishita K.

Cell Growth Differ. 1999 Aug;10(8):565-73.

Supplemental Content

Support Center